Intimation of the Closure of Trading Window
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies Limited has informed the BSE that the trading window for dealing in its equity shares will remain closed for all directors, promoters, designated persons, and insiders starting October 1, 2025. The window will reopen only 48 hours after the declaration and publication of unaudited financial results for the half-year ended September 30, 2025. This is a standard compliance measure under SEBI's Insider Trading Regulations, 2015, and the company's own insider trading code. The intimation was signed by Managing Director Bhumishth Patel on September 30, 2025.
This is a routine regulatory disclosure and does not directly affect shareholders. The upcoming closure suggests unaudited half-yearly results will be announced soon, which investors should watch for as it may influence stock sentiment.